{"id":6749,"date":"2021-03-10T10:50:34","date_gmt":"2021-03-10T09:50:34","guid":{"rendered":"https:\/\/beigen.vipdev.lndo.site\/?post_type=webcast&p=6749"},"modified":"2025-10-11T14:43:42","modified_gmt":"2025-10-11T12:43:42","slug":"relapsed-refractory-waldenstroms-macroglobulinemia-key-considerations-for-managing-pre-treated-patients","status":"publish","type":"webcast","link":"https:\/\/beonemedaffairs.com\/begenius\/webcast\/6749\/relapsed-refractory-waldenstroms-macroglobulinemia-key-considerations-for-managing-pre-treated-patients\/","title":{"rendered":"Relapsed\/refractory Waldenstr\u00f6m\u2019s macroglobulinemia: Key considerations for managing pre-treated patients"},"content":{"rendered":"","protected":false},"template":"","class_list":["post-6749","webcast","type-webcast","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/beonemedaffairs.com\/begenius\/wp-json\/wp\/v2\/webcast\/6749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beonemedaffairs.com\/begenius\/wp-json\/wp\/v2\/webcast"}],"about":[{"href":"https:\/\/beonemedaffairs.com\/begenius\/wp-json\/wp\/v2\/types\/webcast"}],"wp:attachment":[{"href":"https:\/\/beonemedaffairs.com\/begenius\/wp-json\/wp\/v2\/media?parent=6749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}